Eiger BioPharmaceuticals Inc Shares Close in on 52-Week Low - Market Mover
The shares closed 1.5% above its 52-week low of $4.78, with trading volume lower than its 30 day average
Jan 11, 2022 by Kwhen Finance Editors
Eiger BioPharmaceuticals Inc (EIGR) shares closed today at 1.5% above its 52 week low of $4.78, giving the company a market cap of $165M. The stock is currently down 6.0% year-to-date, down 58.2% over the past 12 months, and down 58.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 43.3% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|
Eiger BioPharmaceuticals Inc | -0.6 | -6.0 | -58.2 | -63.8 | 2.1 |
Dow Jones Industrial Average | -0.4 | -0.3 | 18.5 | -2.3 | 22.9 |
S&P 500 Index | -0.1 | -1.9 | 23.9 | -3.6 | 27.3 |
Health Care | -0.0 | -5.2 | 13.2 | -6.3 | 20.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -422.9%
- The company's stock price performance over the past 12 months lags the peer average by 313.9%
Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
---|---|---|---|---|---|---|
Eiger BioPharmaceuticals Inc | EIGR | 0 | -6.0 | -58.2 | -63.8 | 2.1 |
Peer Avg | N/A | 4.6 | 1.9 | -14.1 | -21.2 | 14.6 |
National Research Corp | NRC | 28.8 | -1.8 | -8.9 | -26.3 | 4.2 |
Nymox Pharmaceutical Corp | NYMX | -10.4 | 9.2 | -47.4 | -58.6 | 54.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: